Galway researchers have secured substantial funding exceeding €11 million to address critical health challenges through innovative projects focusing on medicine targeting, sustainable devices, and inclusivity in research. Four distinguished researchers at the University of Galway have been awarded grants under the European Commission’s Marie Skłodowska Curie Actions-Doctoral Network programme (MSCA DN), a significant component of Horizon Europe 2020. These projects aim to revolutionize medical treatments by enhancing their safety, efficacy, and speed.
Dr. Mihai Lomora is spearheading a €4.2 million project, ‘CerebroMachinesTrain,’ utilizing advanced 3D brain models to test miniature machines designed to precisely deliver medicine to targeted areas. This groundbreaking project eliminates the need for animal testing, resulting in faster, more ethical, and accurate research practices. With 14 partners across eight countries, the project is set to support four PhD students, driving innovation at the intersection of drug delivery and brain models.
In his role as a lecturer and principal investigator in bio(material) chemistry at the School of Biological and Chemical Sciences, Dr. Lomora emphasized the transformative impact of combining advanced drug delivery with relevant brain models. This integration not only accelerates research processes but also diminishes reliance on animal testing, marking a significant advancement for both scientific advancement and societal welfare.
Dr. William Ronan is leading a €2.71 million project named ‘Medalloy,’ which focuses on enhancing the durability and longevity of minimally invasive medical devices like stents and heart valve supports. The project, involving partners from six countries, aims to train nine PhD students, propelling advancements in biomedical engineering. Ronan, a lecturer and principal investigator in biomedical engineering at the College of Science and Engineering, highlighted the project’s objective of enhancing the durability and affordability of life-saving heart devices through the optimization of Nitinol, a remarkable material.
Dr. Eimear Morrissey heads the €4.4 million ‘Edict’ research project, which seeks to enhance inclusivity in clinical trials by targeting older adults, ethnic minorities, individuals with disabilities, and those from lower-income backgrounds. This initiative, led by the Health Research Board-Trials Methodology Research Network at the University of Galway, aims to develop tools, methods, and policies to foster inclusivity, fairness, and effectiveness in clinical trials across Europe. Through training 16 PhD researchers across 26 organizations in 12 countries, Morrissey’s project aims to address the underrepresentation of diverse populations in clinical trials.
Dr. Muireann O’Cinneide is involved in a unique collaborative project between the University of Galway, Goldsmiths, University of London, and Galway’s Cúirt International Festival of Literature called ‘Decadocs.’ This doctoral network delves into the study of ‘decadence,’ exploring late nineteenth-century travel and mobility’s influence on counter-cultural sexualities and complex imperial identities. O’Cinneide, a researcher in English, media, and creative arts at the College of Arts, Social Sciences, and Celtic Studies, highlighted how ‘Decadocs’ aims to reshape cultural reception frameworks and reimagine geographies and futures through alternative cultural encounters.
The MSCA-DN programme plays a pivotal role in enhancing researchers’ creativity, entrepreneurship, and innovation, thereby bolstering their long-term employability. Prof. Fidelma Dunne, the director of the Institute for Clinical Trials at the University of Galway, commended these projects for their tangible impact on people’s lives. The University of Galway stands at the forefront of creating smarter, safer, and more sustainable healthcare solutions, reflecting its commitment to driving positive change in the healthcare landscape.
The interdisciplinary collaborations and innovative projects led by Galway researchers underscore the transformative potential of research and development in healthcare. By leveraging cutting-edge technologies, advanced methodologies, and collaborative networks, these initiatives are poised to revolutionize medical treatments, enhance inclusivity in clinical trials, and explore complex socio-cultural phenomena. Through a combination of scientific rigor, ethical considerations, and a commitment to societal impact, these projects exemplify the University of Galway’s dedication to advancing healthcare innovation on a global scale.
Takeaways:
– Innovative projects led by Galway researchers are revolutionizing medical treatments through advanced drug delivery systems, durable medical devices, and inclusive clinical trial methodologies.
– The University of Galway’s commitment to interdisciplinary collaboration and societal impact is driving transformative change in healthcare research.
– By focusing on cutting-edge technologies, ethical research practices, and inclusivity, these projects are poised to shape the future of healthcare on a global scale.
Tags: drug delivery, clinical trials
Read more on siliconrepublic.com